CRUK Birmingham Centre

• Health & Medicine

New neuroblastoma treatment combo helps more children with relapsed disease

We helped fund a trial into neuroblastoma treatment that has improved how doctors treat the disease when other options aren't working. It's an important step forward in treating these relapsed and refractory tumours, which have some of the lowest survival rates for any childhood cancer.   We helped fund a trial into neuroblastoma treatment that has improved how doctors treat the disease when other options aren't working. It's an important step forward in treating these relapsed and refractory tumours, which have some of the lowest survival rates for any childhood cancer.  

10 January 2024

• Science & Technology

The path to least resistance: How our researchers are outsmarting cancer’s survival skills

Our scientists across the country are working hard to tackle drug resistance – one of cancer's cruellest curveballs. Our scientists across the country are working hard to tackle drug resistance – one of cancer's cruellest curveballs.

25 May 2022